Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients
Launched by UNIVERSIDADE DO VALE DO SAPUCAI · Feb 20, 2018
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
Keratosis in feet or plantar callosity is an injury caused by friction or pressure in certain location of the skin. This is a common problem faced by diabetic patients, which usually cause subcutaneous tissue maceration, which favors bacterial invasion. It is responsible for the development of abscesses and ulcers. Ulcer is the main cause of non-traumatic amputation of the feet in diabetic patients. Treatment with medicinal plants is an ancient practice. Brazil has one of the richest floras in the world. Brazilian Ministry of Health recommends the rational use of medicinal plants and encour...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - diabetic patients type 1 and 2 with plantar keratosis
- Exclusion Criteria:
- • - feet ulcerated lesions
About Universidade Do Vale Do Sapucai
Universidade do Vale do Sapucaí is a reputable academic institution dedicated to advancing healthcare research and innovation. As a clinical trial sponsor, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and contributing to scientific knowledge. With a commitment to ethical standards and collaboration, the university fosters partnerships with healthcare professionals and industry stakeholders to ensure that its research is both impactful and aligned with the needs of the community. Through these efforts, Universidade do Vale do Sapucaí plays a vital role in translating research findings into practical applications in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pouso Alegre, Minas Gerais, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials